Completed Food & Agriculture Pregnancy, Children & Inherited Conditions

Lessons learned from previous international science panels: implications for the new independent panel for evidence for action against antimicrobial resistance

In plain English

AI plain-English summary

In September 2024, the United Nations committed to creating a new independent panel to coordinate the global fight against antimicrobial resistance (AMR)—but no one has yet decided exactly how that panel should work. This project fills a critical gap. AMR, where bacteria evolve to defeat antibiotics, threatens to make routine infections and surgeries deadly. Previous international science panels—on climate change, biodiversity, and chemicals—offer lessons on what works and what does not. But those lessons have never been systematically gathered for the AMR panel’s designers. The Nigerian Academy of Sciences and US National Academy of Medicine are convening a strategic dialogue in early 2025 to document those lessons. The Center for Global Development is funding an eight-month project to prepare briefing materials for that dialogue and to amplify its conclusions. If successful, this work will shape the panel’s composition, mandate, and deliverables from the start—avoiding mistakes that plagued earlier panels and ensuring the new body produces actionable evidence quickly. The result could mean faster, more effective international responses to drug-resistant infections, protecting the antibiotics that underpin modern medicine, surgery, and agriculture.

View original technical description
Antimicrobial resistance (AMR) poses a significant threat to global health and economic stability. In recognition of this, at the United Nations General Assembly’s High-Level Meeting on AMR in September 2024, countries worldwide committed to establishing an independent panel on AMR. This development is widely regarded by the AMR community as a pivotal step toward addressing the growing global challenge of AMR. However, the composition, mandate, scope and deliverables of this independent panel are yet to be defined. The Nigerian Academy of Sciences and US National Academy of Medicine, will lead an effort to convene a strategic dialogue in early 2025, aimed at documenting and reflecting on “Lessons Learned” from previous international panels. This initiative is co-led by Professor Iruka N. Okeke (University of Ibadan); Professor Kevin Outterson (CARB-X & Boston University); and Javier Guzman (Center for Global Development -CGD). CGD seeks funding from the Wellcome Trust for a 8-month project aimed at supporting the Lessons Learned strategic dialogue by preparing key materials to inform the discussions and amplifying the dissemination of key takeaways from the convening. This work will be done in partnership with researchers at the University of Ibadan, the Global Strategy Lab and the South Center.

View the original record at the funder ↗

Researchers

Javier Guzman (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

East Africa AMR-STOP: Strategies for Tackling, Optimising and Preventing Environmental AMR (AfricaAMR-STOP)
NIHR Global Health Research Group on Vaccines to Control Respiratory Pathogens & AMR across Africa (VacAMR)
NIAMR: Developing and Evaluating a National Integrated Digital Data Capture and Sharing Platform for Enhanced Detection and Monitoring of Antimicrobial Resistance to Improve One Health AMR Surveillance and Management in Uganda
The environmental dimension of antimicrobial resistance: informing policy, regulation and practice.
Supporting the National Action Plan on AMR in Tanzania (SNAP-AMR)

Original classification

Discretionary Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.